WAS - Competitive Landscape and Market Insight, 2019

WAS - Competitive Landscape and Market Insight, 2019

  • Pages: 54
  • Geography: Global
  • Delivery Timeline: 24 Hours
  • Publication: Jul, 2019
  • SKU: DISR0018
  • Single User License
    (20% Off)
    $4,750.00
  • Site License
    (30% Off)
    $9,500.00
  • Global License
    (40% Off)
    $14,250.00
Request Sample

Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Address*  
Message*  
X

Request Sample Pages

Request Before Buy
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Inquire Before Buy

Send Friend
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Send to Friend

Introduction
Executive Summary
Wiskott-Aldrich Syndrome (WAS)
Overview
Clinical Features
Pathophysiology
Signs and Symptoms
Diagnosis
Treatment
Epidemiology Overview - 7MM, 2015-2028
Prevalence of Wiskott-Aldrich Syndrome in 7MM
Epidemiology of Wiskott-Aldrich Syndrome in 7 MM
Assumptions and Rationale
Prevalent Population of Wiskott-Aldrich Syndrome in 7MM
Incident Population of Wiskott-Aldrich Syndrome in 7MM
Competitive Landscape
Pipeline Scenario
Late Stage Products (Phase III)
Comparative Analysis
GSK2696275: GlaxoSmithKline
Product Description
Research and Development
Heat Map
Product Development Activities
GSK2696275, 7MM Forecasted Sales
GSK2696275 – Analyst Insight
Mid-Stage Products
Comparative Analysis
Market Assessment
Wiskott-Aldrich Syndrome – Share Evolution
7MM Market Size of Wiskott-Aldrich Syndrome
Historical & Forecasted Market Size
Attribute Analysis
Analysis
Potential Matrix
Analysis
Unmet Need
Appendix

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Table 1: Late Stage Products (Phase III)
Table 2: GSK2696275 Forecasted Sales (2021-2028)
Table 3: Mid Stage Products (Phase II)
Table 4: Drug 2 Forecasted Sales (2021-2028)
Table 5: Drug 3 Forecasted Sales (2021-2028)
Table 6: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Table 7: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Table 8: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Figure 1: Chromosomal Representation of Wiskott-Aldrich Syndrome protein (WASp)
Figure 2: Late Stage Products (Phase III)
Figure 3: GSK2696275 Forecasted Sales (2021-2028)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Drug 2 Forecasted Sales (2021-2028)
Figure 6: Drug 3 Forecasted Sales (2021-2028)
Figure 7: 7MM, Historical & Forecasted Prevalent Cases, 2015-2028
Figure 8: 7MM, Historical & Forecasted Incident Cases, 2015-2028
Figure 9: 7MM, Historical & Forecasted Market Size of Wiskott-Aldrich Syndrome, 2015-2028

 

Key Companies
Speak to Analyst
Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Specific Filed of Interest*  
X

Speak to Analyst

+1(919)321-6187

Related Reports

Contact Us

Phone

India: +91-11-45689769, +91-9650213330

Email

info@delveinsight.com

Address

New Delhi-110075, India

Address

304 S. Jones Blvd #2432, Las Vegas NV 89107

Phone

Outside India: +1(919)321-6187

Latest Tweets

Copyright © 2018 Delveinsight.